15th Jan 2018 07:00
ADAMAS FINANCE ASIA LIMITED
(the "Company" or the "Group")
FURTHER RE. DISPOSAL OF INTEREST IN GLOBAL PHARM
On 15 September 2017, Adamas Finance Asia Limited, a London quoted pan-Asian diversified investment vehicle, announced the disposal of the Group's interest in Global Pharm Holdings Group Inc. (the "Transaction").
Under the terms of the Transaction, the consideration of US$15.6 million in cash, was due for payment by the purchaser, Fortune Insight Limited, within 120 days of 15 September 2017. On 12 January 2018, the Company agreed to extend the date for payment to 31 March 2018.
A further announcement will be made in due course.
Enquiries:
Adamas Finance Asia Limited | |
John Croft | +44 (0) 1825 830587 |
WH Ireland Limited - Nominated Adviser | |
Tim Feather James Sinclair-Ford | +44 (0) 113 394 6600
|
finnCap Limited - Broker | |
William Marle Grant Bergman | +44 (0) 20 7220 0500 |
Buchanan - Financial PR Charles Ryland Victoria Hayns Henry Wilson |
+44 (0) 20 7466 5000 |
About Adamas Finance Asia
ADAM is a London quoted investment company focusing on delivering long-term income and capital growth to shareholders through a diverse portfolio of pan-Asian investments.
ADAM aims to provide uncorrelated returns through a combination of capital growth and dividend income from a broad spectrum of national geographies and asset classes.
The Company's investment manager Harmony Capital, which has a dedicated team with real Asian expertise, will focus on the strategy of creating income and capital growth as well as addressing the issues of the ongoing legacy portfolio. Harmony is sourcing predominately private opportunities and a strong pipeline already exists. Income generating assets include investments in property, mining, pharmaceuticals, and telecoms across Asia.
Related Shares:
ADAM.L